These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8674615)
1. The synthesis and characterisation of a glyoxal inhibitor of chymotrypsin. Murphy EA; O'Connell TP; Malthouse JP Biochem Soc Trans; 1996 Feb; 24(1):129S. PubMed ID: 8674615 [No Abstract] [Full Text] [Related]
2. 13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor. Djurdjevic-Pahl A; Hewage C; Malthouse JP Biochem J; 2002 Mar; 362(Pt 2):339-47. PubMed ID: 11853541 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors. Obreza A; Stegnar M; Trampus-Bakija A; Prezelj A; Urleb U Pharmazie; 2004 Oct; 59(10):739-43. PubMed ID: 15544050 [TBL] [Abstract][Full Text] [Related]
4. Alpha-ketoester-based photobiological switches: synthesis, peptide chain extension and assay against alpha-chymotrypsin. Harvey AJ; Abell AD Bioorg Med Chem Lett; 2001 Sep; 11(18):2441-4. PubMed ID: 11549442 [TBL] [Abstract][Full Text] [Related]
5. Design of plasma kallikrein inhibitors: functional and structural requirements of plasma kallikrein inhibitors. Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):452-7. PubMed ID: 9549887 [TBL] [Abstract][Full Text] [Related]
6. Leucine-phenylalanine dipeptide-based N-mesyloxysuccinimides: synthesis of all four stereoisomers and their assay against serine proteases. Abell AD; Oldham MD Bioorg Med Chem Lett; 1999 Feb; 9(3):497-500. PubMed ID: 10091709 [TBL] [Abstract][Full Text] [Related]
7. Peptide glyoxals: a novel class of inhibitor for serine and cysteine proteinases. Walker B; McCarthy N; Healy A; Ye T; McKervey MA Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):321-3. PubMed ID: 8343111 [TBL] [Abstract][Full Text] [Related]
9. Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites. Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N Bioorg Med Chem Lett; 1998 Apr; 8(8):913-8. PubMed ID: 9871511 [TBL] [Abstract][Full Text] [Related]
10. Determination of the structure of tetrahedral transition state analogues bound at the active site of chymotrypsin using 18O and 2H isotope shifts in the 13C NMR spectra of glyoxal inhibitors. Spink E; Hewage C; Malthouse JP Biochemistry; 2007 Nov; 46(44):12868-74. PubMed ID: 17927215 [TBL] [Abstract][Full Text] [Related]
11. Ring-deactivated hydroxyalkylpyrrole-based inhibitors of alpha-chymotrypsin: synthesis and mechanism of action. Martyn DC; Vernall AJ; Clark BM; Abell AD Org Biomol Chem; 2003 Jun; 1(12):2103-10. PubMed ID: 12945901 [TBL] [Abstract][Full Text] [Related]
12. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity. Pochet L; Doucet C; Schynts M; Thierry N; Boggetto N; Pirotte B; Jiang KY; Masereel B; de Tullio P; Delarge J; Reboud-Ravaux M J Med Chem; 1996 Jun; 39(13):2579-85. PubMed ID: 8691456 [TBL] [Abstract][Full Text] [Related]
13. Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site. Eda M; Ashimori A; Akahoshi F; Yoshimura T; Inoue Y; Fukaya C; Nakajima M; Fukuyama H; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N Bioorg Med Chem Lett; 1998 Apr; 8(8):919-24. PubMed ID: 9871512 [TBL] [Abstract][Full Text] [Related]
14. Novel diphenyl esters of peptidyl alpha-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin. Pietrusewicz E; Sieńczyk M; Oleksyszyn J J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1229-36. PubMed ID: 19912056 [TBL] [Abstract][Full Text] [Related]
15. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin. Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737 [TBL] [Abstract][Full Text] [Related]
16. Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position. Obreza A; Stegnar M; Urleb U Pharmazie; 2004 Sep; 59(9):659-67. PubMed ID: 15497744 [TBL] [Abstract][Full Text] [Related]
17. Kinetics study on a novel natural inhibitor of alpha-chymotrypsin. Ahmad VU; Lodhi MA; Abbasi MA; Choudhary MI Fitoterapia; 2008 Dec; 79(7-8):505-8. PubMed ID: 18620032 [TBL] [Abstract][Full Text] [Related]
18. Ring-deactivated hydroxymethylpyrroles as inhibitors of alpha-chymotrypsin. Abell AD; Nabbs BK Bioorg Med Chem; 2001 Mar; 9(3):621-8. PubMed ID: 11310596 [TBL] [Abstract][Full Text] [Related]
19. Quantifying tetrahedral adduct formation and stabilization in the cysteine and the serine proteases. Cleary JA; Doherty W; Evans P; Malthouse JP Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1382-91. PubMed ID: 26169698 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap. Brouwer AJ; Ceylan T; Jonker AM; van der Linden T; Liskamp RM Bioorg Med Chem; 2011 Apr; 19(7):2397-406. PubMed ID: 21421320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]